Holen Sie sich die Stockscreener-App
3.24
2.11%
-0.07
Handel nachbörslich:
3.35
0.11
+3.40%
Schlusskurs vom Vortag:
$3.31
Offen:
$3.3
24-Stunden-Volumen:
94,142
Relative Volume:
1.44
Marktkapitalisierung:
$50.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.31M
KGV:
-4.2078
EPS:
-0.77
Netto-Cashflow:
$-12.65M
1W Leistung:
-3.28%
1M Leistung:
+5.88%
6M Leistung:
+14.08%
1J Leistung:
-9.50%
1-Tages-Spanne:
$3.24
$3.42
1-Wochen-Bereich:
$3.24
$3.5401
52-Wochen-Spanne:
$1.75
$4.685
Grace Therapeutics Inc Stock (GRCE) Company Profile
Firmenname
Grace Therapeutics Inc
Sektor
Branche
Telefon
609-322-1602
Adresse
103 CARNEGIE CENTER, PRINCETON
Vergleichen Sie GRCE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.24 | 51.22M | 0 | -10.31M | -12.65M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Eingeleitet | TD Cowen | Buy |
| 2020-09-01 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-07-06 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | Eingeleitet | B. Riley FBR | Buy |
| 2019-07-18 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Grace Therapeutics Inc Aktie (GRCE) Neueste Nachrichten
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort - pharmiweb.com
Winners Losers: Why retail investors favor Grace Therapeutics Inc stock2025 Volume Leaders & Trade Opportunity Analysis - moha.gov.vn
Grace and Molecule.one to Transform Peptide Building Block Synthesis with AI and Automation - Yahoo Finance
Is Grace Therapeutics Inc. stock attractive for long term wealth buildingIPO Watch & Safe Capital Preservation Plans - Newser
Why Grace Therapeutics Inc. stock is popular among millennials2025 Retail Activity & Stepwise Trade Execution Plans - Newser
Grace Therapeutics (GRCE) Stock Analysis Report | Financials & Insights - Benzinga
Is Grace Therapeutics Inc. stock supported by strong fundamentalsTreasury Yields & Short-Term High Return Ideas - moha.gov.vn
What analysts say about Grace Therapeutics Inc stockHigh Frequency Trading Trends & Access High Yield Alerts - earlytimes.in
Why retail investors pile into Grace Therapeutics Inc. stockJuly 2025 Fed Impact & Technical Buy Zone Confirmations - newser.com
Why Grace Therapeutics Inc. stock could rally in 2025Short Setup & Safe Entry Momentum Stock Tips - newser.com
Using RSI to spot recovery in Grace Therapeutics Inc.Trend Reversal & Low Volatility Stock Recommendations - newser.com
Will Grace Therapeutics Inc. stock maintain growth storyWeekly Gains Report & Expert Approved Trade Ideas - newser.com
Will Grace Therapeutics Inc. stock outperform Nasdaq index - newser.com
Can Grace Therapeutics Inc. stock rebound after recent weakness2025 Institutional Moves & Fast Momentum Stock Entry Tips - newser.com
Will Grace Therapeutics Inc. stock outperform value stocks2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
Grace Therapeutics Inc. stock outlook for YEARMarket Performance Summary & Community Consensus Picks - newser.com
Kempinski Grace Bay Breaks Ground on Turks and Caicos' Iconic Grace Bay Beach - Yahoo Finance
Building trade automation scripts for Grace Therapeutics Inc.July 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Grace Therapeutics to Participate in 16th Annual Craig-Hallum Alpha Select Conference - The Manila Times
Grace Therapeutics (Nasdaq: GRCE) joins Craig-Hallum 16th Alpha Select Conference - Stock Titan
Can Grace Therapeutics Inc. stock resist market sell offsWeekly Trade Review & Verified Chart Pattern Trade Signals - newser.com
Finanzdaten der Grace Therapeutics Inc-Aktie (GRCE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):